BHB & CAR-T for Lymphomas

Clinical trial NCT06610344 · RECRUITING

Trial details

NCT number: NCT06610344
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2025-01-07
Primary completion: 2026-09-15
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.